Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment

J Am Coll Cardiol. 2020 May 26;75(20):2623-2624. doi: 10.1016/j.jacc.2020.04.016. Epub 2020 Apr 10.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / metabolism
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / metabolism
  • Antiviral Agents / adverse effects
  • Antiviral Agents / metabolism
  • Azithromycin / adverse effects*
  • Azithromycin / metabolism
  • Betacoronavirus / drug effects*
  • Betacoronavirus / metabolism
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / metabolism
  • Drug Interactions / physiology
  • Drug Repositioning / methods
  • Electrocardiography / drug effects
  • Electrocardiography / methods
  • Humans
  • Hydroxychloroquine / adverse effects*
  • Hydroxychloroquine / metabolism
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / metabolism
  • SARS-CoV-2
  • Torsades de Pointes / chemically induced*
  • Torsades de Pointes / metabolism
  • Torsades de Pointes / physiopathology

Substances

  • Anti-Bacterial Agents
  • Antirheumatic Agents
  • Antiviral Agents
  • Hydroxychloroquine
  • Azithromycin